Ilmarinen Mutual Pension Insurance Co bought a new stake in Cigna Group (NYSE:CI - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 26,000 shares of the health services provider's stock, valued at approximately $7,156,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CI. Northwestern Mutual Wealth Management Co. lifted its holdings in Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider's stock valued at $900,912,000 after acquiring an additional 3,141,844 shares during the period. Capital Research Global Investors raised its stake in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider's stock worth $916,434,000 after buying an additional 1,855,897 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock worth $3,249,113,000 after buying an additional 903,334 shares during the last quarter. Ameriprise Financial Inc. raised its stake in shares of Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider's stock worth $615,781,000 after buying an additional 753,865 shares during the last quarter. Finally, M&T Bank Corp increased its position in Cigna Group by 1,299.3% during the 4th quarter. M&T Bank Corp now owns 635,706 shares of the health services provider's stock worth $174,965,000 after purchasing an additional 590,277 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.
Analyst Ratings Changes
CI has been the subject of a number of recent research reports. Piper Sandler dropped their price objective on Cigna Group from $374.00 to $370.00 and set an "overweight" rating for the company in a research report on Tuesday, March 3rd. The Goldman Sachs Group boosted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a "buy" rating in a report on Monday, May 4th. Robert W. Baird set a $337.00 target price on Cigna Group in a report on Friday, May 1st. Guggenheim boosted their target price on Cigna Group from $334.00 to $338.00 and gave the stock a "buy" rating in a report on Monday, May 4th. Finally, TD Cowen boosted their target price on Cigna Group from $333.00 to $338.00 and gave the stock a "buy" rating in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $339.50.
Check Out Our Latest Stock Report on CI
Cigna Group Stock Performance
Shares of CI opened at $284.62 on Friday. The business's 50 day moving average is $278.07 and its two-hundred day moving average is $276.88. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89. The firm has a market cap of $75.29 billion, a price-to-earnings ratio of 12.07, a PEG ratio of 1.03 and a beta of 0.30. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.
Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same period in the prior year, the company posted $6.74 EPS. Cigna Group's quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.
Cigna Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group's dividend payout ratio is currently 26.45%.
Insider Activity at Cigna Group
In related news, CEO David Cordani sold 201,878 shares of the company's stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 205,904 shares of company stock valued at $60,277,068. Corporate insiders own 0.60% of the company's stock.
Cigna Group Profile
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report